NCT07639164

Brief Summary

The main objective of the current research project is to evaluate the usability, satisfaction of the antenatal iCBT program including telephone coaching for antenatal and postnatal depressive symptoms and collect nationally representative data on population-based screening of antenatal depressive and anxiety symptoms. The overarching hypothesis is that iCBT, with easy access and affordability, is user friendly and well accepted. In addition to examining the treatment response by questionnaires, we will study the infant development comprehensively as well as potential physiological changes associated with antenatal depression or its treatment.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
54mo left

Started Aug 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2030

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2030

Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

4.4 years

First QC Date

June 5, 2026

Last Update Submit

June 5, 2026

Conditions

Keywords

Digital interventionCognitive Behaviour TherapyAntenatal depression

Outcome Measures

Primary Outcomes (1)

  • Change in the Edinburgh Postnatal Depression Scale (EPDS)

    EPDS is a ten-item self-report questionnaire originally developed to screen for postpartum depression. The respondents are asked about the symptoms of depression. The total score ranges from 0 to 30.

    Baseline and 11 weeks after baseline

Secondary Outcomes (5)

  • Change in the General Anxiety Disorder 7-item scale (GAD-7)

    Baseline and 11 weeks after baseline

  • Change in the Beck Depression Inventory II (BDI-II)

    Baseline and 11 weeks after baseline

  • Social Phobia Inventory (SPIN)

    Baseline and 11 weeks after baseline

  • Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ)

    Baseline and 11 weeks after baseline

  • Perceived Stress Scale (PSS)

    Baseline and 11 weeks after baseline

Study Arms (1)

CBT Intervention

EXPERIMENTAL

Digitalized CBT intervention with phone coaching Arm Description: Participants receive weekly sessions of internet-based CBT, including telephone coaching

Behavioral: Digitalized CBT with phone coaching

Interventions

Digitally delivered CBT intervention with weekly phone coaching

CBT Intervention

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • fluent in written and spoken Finnish or Swedish
  • access to computer or mobile phone with internet
  • between 12 and 22 weeks pregnant
  • screening and baseline score on the EPDS ≥10 points

You may not qualify if:

  • lifetime history of psychotic disorder (e.g. schizophrenia, schizoaffective disorder, bipolar disorder, psychotic depression)
  • active suicidal ideation
  • severe substance abuse or dependence
  • participates in another intervention study aiming at treating the symptoms of antenatal depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Turku

Turku, Finland

Location

MeSH Terms

Conditions

DepressionDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Andre Sourander, Professor

    Uiniversity of Turku

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 5, 2026

First Posted

June 10, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

December 30, 2030

Study Completion (Estimated)

December 30, 2030

Last Updated

June 10, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations